Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02835300 · ClinicalTrials.gov registry record · Phase 2
Mobile Technology and Online Tools to Improve Asthma Control in Adolescents
A Phase 2 study of Asthma, sponsored by 3-C Institute for Social Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 79
- Enrollment target
- 1
- Study location
NCT02835300 is a Phase 2 study of Asthma that has completed, run by 3-C Institute for Social Development. The registered enrollment target is 79 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02835300, a Phase 2 study of Asthma, has completed, sponsored by 3-C Institute for Social Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 79 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will preliminarily validate CampAir, an empirically-based dynamic e-health intervention (based on the evidence-based ASMA) to assist adolescents with uncontrolled asthma to learn how to manage their illness and improve their asthma control. In addition to developing a highly novel product for adolescents with asthma, the research proposed for this project will address unique scientific questions. Despite the high asthma prevalence among adolescents, few interventions have specifically targeted adolescents. This study is innovative in that it is among the few to focus on adolescents, who are often overlooked by the healthcare system. This research will assess factors associated with successful implementation of CampAir, thereby providing new information regarding how e-health interventions can be effectively developed and implemented for use with adolescents with asthma.
Conditions Studied
Interventions
- BEHAVIORAL CampAir
- BEHAVIORAL Information and Referral
Study Locations (1)
North Carolina
- 3-C Institute for Social Development, dba 3C Institute - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2016-12 |
| Est. Completion | 2017-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02835300
The ClinicalTrials.gov registry entry for NCT02835300 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (95% lower). The listed sponsor is 3-C Institute for Social Development, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which CampAir is the first listed.
NCT02835300 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT02835300 about?
NCT02835300 is a clinical study titled "Mobile Technology and Online Tools to Improve Asthma Control in Adolescents". This project will preliminarily validate CampAir, an empirically-based dynamic e-health intervention (based on the evidence-based ASMA) to assist adolescents with uncontrolled asthma to learn how to manage their illness and improve their asthma control. In addition to developing a highly novel produ...
What is the current status of trial NCT02835300?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 79 participants. The study started on 2016-12. Estimated completion is 2017-05.
What conditions does trial NCT02835300 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT02835300?
The interventions under investigation include: CampAir (BEHAVIORAL), Information and Referral (BEHAVIORAL).
Who is sponsoring clinical trial NCT02835300?
This trial is sponsored by 3-C Institute for Social Development, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02835300 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.